- Home
- ALUR vs CLGN Comparison
ALUR vs CLGN Comparison
Compare ALUR & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALUR
- CLGN
- Stock Information
- Founded
- ALUR 2009
- CLGN 2004
- Country
- ALUR United States
- CLGN Israel
- Employees
- ALUR N/A
- CLGN N/A
- Industry
- ALUR
- CLGN Industrial Specialties
- Sector
- ALUR
- CLGN Health Care
- Exchange
- ALUR Nasdaq
- CLGN Nasdaq
- Market Cap
- ALUR 18.0M
- CLGN 19.1M
- IPO Year
- ALUR N/A
- CLGN N/A
- Fundamental
- Price
- ALUR $3.02
- CLGN $2.31
- Analyst Decision
- ALUR Strong Buy
- CLGN Strong Buy
- Analyst Count
- ALUR 3
- CLGN 2
- Target Price
- ALUR $22.83
- CLGN $11.50
- AVG Volume (30 Days)
- ALUR 213.4K
- CLGN 70.3K
- Earning Date
- ALUR 08-12-2025
- CLGN 08-19-2025
- Dividend Yield
- ALUR N/A
- CLGN N/A
- EPS Growth
- ALUR N/A
- CLGN N/A
- EPS
- ALUR N/A
- CLGN N/A
- Revenue
- ALUR $28,304,000.00
- CLGN $2,472,000.00
- Revenue This Year
- ALUR N/A
- CLGN $1,999.42
- Revenue Next Year
- ALUR $49.37
- CLGN $69.81
- P/E Ratio
- ALUR N/A
- CLGN N/A
- Revenue Growth
- ALUR N/A
- CLGN N/A
- 52 Week Low
- ALUR $2.15
- CLGN $1.31
- 52 Week High
- ALUR $22.63
- CLGN $5.45
- Technical
- Relative Strength Index (RSI)
- ALUR 55.72
- CLGN 65.19
- Support Level
- ALUR $3.05
- CLGN $2.16
- Resistance Level
- ALUR $3.33
- CLGN $2.28
- Average True Range (ATR)
- ALUR 0.23
- CLGN 0.18
- MACD
- ALUR 0.02
- CLGN 0.11
- Stochastic Oscillator
- ALUR 63.49
- CLGN 86.24
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.